Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
32.04
+0.32 (1.01%)
Apr 29, 2026, 3:00 PM CST

SHA:600976 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
161.85113.71163.17305.12219.33301.66
Short-Term Investments
-136.51----
Trading Asset Securities
966.27954.14954.19694.46641.38538.63
Cash & Short-Term Investments
1,1281,2041,117999.58860.71840.28
Cash Growth
-6.30%7.79%11.78%16.13%2.43%45.64%
Accounts Receivable
1,1441,040957.561,150868.66674.6
Other Receivables
46.17123.825.7631.4349.6421.43
Receivables
1,1901,164983.331,181918.29696.03
Inventory
327.84286.57354.31450.85362.88222.6
Other Current Assets
148.394.89146.43134.06162.85104.5
Total Current Assets
2,7952,7502,6012,7662,3051,863
Property, Plant & Equipment
690.72698.07595.59450.7417.65396.65
Long-Term Investments
842.63722.3772.18650.42444.94326.85
Goodwill
0.210.210.210.210.210.21
Other Intangible Assets
26.6527.5328.1928.8731.1632.98
Long-Term Deferred Tax Assets
186.85180.34129.49139.44117.27118.33
Long-Term Deferred Charges
135.43136.33130.78111.2791.6687.64
Other Long-Term Assets
11.2612.1619.7421.1432.5630.01
Total Assets
4,6884,5274,2784,1683,4402,856
Accounts Payable
655.97642.52742.22782.91611.06374.92
Accrued Expenses
32.75716.3574.78724.73620.32592.57
Short-Term Debt
2055.05140.979.4522.5245
Current Portion of Leases
6.785.626.395.127.346.1
Current Income Taxes Payable
135.1104.0552.7466.2349.6871.75
Current Unearned Revenue
26.4536.1961.4341.1982.5237.04
Other Current Liabilities
930.45176.11166.66157.31140.25191.85
Total Current Liabilities
1,8071,7361,7451,8571,5341,319
Long-Term Debt
34.334.034---
Long-Term Leases
34.4531.0324.4330.2923.4820.37
Long-Term Unearned Revenue
42.1444.4146.5518.6112.1827.72
Long-Term Deferred Tax Liabilities
4.84.87.25.625.970.84
Total Liabilities
1,9231,8501,8271,9111,5751,368
Common Stock
153.4153.4153.4153.4153.4153.4
Additional Paid-In Capital
522.73522.73523.42520.68509.17421.5
Retained Earnings
2,0681,9801,7581,5801,212931.06
Treasury Stock
----6.76-14.99-25.08
Total Common Equity
2,7442,6562,4352,2481,8601,481
Minority Interest
20.9820.415.038.784.997.04
Shareholders' Equity
2,7652,6772,4502,2561,8651,488
Total Liabilities & Equity
4,6884,5274,2784,1683,4402,856
Total Debt
95.53125.73175.71114.8653.3471.48
Net Cash (Debt)
1,0331,079941.65884.72807.37768.81
Net Cash Growth
-1.69%14.55%6.44%9.58%5.02%38.07%
Net Cash Per Share
6.737.106.195.795.305.06
Filing Date Shares Outstanding
153.4153.4153.4153.82152.78151.97
Total Common Shares Outstanding
153.4153.4153.4153.82152.78151.97
Working Capital
987.051,014856.33908.95771.06544.18
Book Value Per Share
17.8917.3215.8814.6112.179.74
Tangible Book Value
2,7172,6292,4072,2191,8291,448
Tangible Book Value Per Share
17.7117.1415.6914.4211.979.53
Buildings
-409.52287.12284.12289.38298.05
Machinery
-485.88314.22312.36301.9251.25
Construction In Progress
-40.17206.6841.4817.1916.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.